Contribution of PAR-1, PARA and GPlbα in intracellular signaling leading to the cleavage of the β3 cytoplasmic domain during thrombin-induced platelet aggregation

被引:10
|
作者
Dubois, C [1 ]
Steiner, B [1 ]
Reigner, SCM [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Div Pharma, Discovery Res, CH-4070 Basel, Switzerland
关键词
integrin alpha llb beta 3; beta 3 cytoplasmic domain; PAR; GPlb beta alpha;
D O I
10.1160/TH03-06-0391
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Integrin alphaIIbbeta3 plays a pivotal role in platelet aggregation by binding to fibrinogen. The beta3 cytoplasmic domain of alphaIIbbeta3 interacts with cytoskeletal and signaling proteins and is cleaved by p-calpain, a calcium regulated cysteine protease. In the present study, we have investigated in more detail the cleavage of the beta3 cytoplasmic domain during platelet aggregation induced by thrombin, TRAP-1 and TRAP-4. Our data show that beta3 is cleaved in all three cases. The time course of beta3 cleavage and the amount of cleaved beta3 depends on the way platelets are activated and on the complete activation of mu-calpain, with a maximum of 90% of cleaved beta3 obtained when thrombin is used. Furthermore, our results also show that the cleaved alphaIIbbeta3 is mainly distributed in the Triton soluble fraction, indicating its inability to bind to the cytoskeleton. Interestingly, in the absence of GPlbalpha or following inhibition of thrombin binding to GPIbalpha, there is a reduction in the thrombin-induced calcium flux, beta3 cleavage and mu-calpain activation. These results suggest that cleavage of the beta3 cytoplasmic domain by mu-calpain might be an important step regulating the link between the cytoskeleton and alphaIIbbeta3 during platelet aggregation, and that GPIbalpha could function as a cofactor for the complete activation of platelets by thrombin.
引用
收藏
页码:733 / 742
页数:10
相关论文
共 14 条
  • [11] The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation
    Wu, Chin-Chung
    Wu, Shih-Yun
    Liao, Chieh-Yu
    Teng, Che-Ming
    Wu, Yang-Chang
    Kuo, Sheng-Chu
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (03) : 643 - 658
  • [12] Antithrombotic effects of the novel inhibitor of thrombin-induced platelet aggregation and thrombus formation, 3-[2-([1,1':2',1'']-terphenyl-4'-yl)ethyl]phenoxyacetic acid
    Miyamae, T
    Hashizume, H
    Ogawa, T
    Okayama, T
    Nukui, E
    Oshima, K
    Morikawa, T
    Hagiwara, M
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1997, 47 (01): : 13 - 18
  • [13] EFFECT OF PROSTAGLANDIN-E2 AND 3-MORPHOLINOSYDNONIMINE (SIN-1) ON ARACHIDONIC-ACID METABOLISM IN FMLP-STIMULATED RAT NEUTROPHILS AND ON THROMBIN-INDUCED HUMAN PLATELET-AGGREGATION
    PALLAPIES, D
    JIRMANN, KU
    RADEMANN, J
    SIMMET, T
    RUTOWSKI, J
    DEMBINSKAKIEC, A
    PESKAR, BA
    AGENTS AND ACTIONS, 1992, 36 (1-2): : 77 - 82
  • [14] HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate
    Nofer, JR
    Walter, M
    Kehrel, B
    Wierwille, S
    Tepel, M
    Seedorf, U
    Assmann, G
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (06) : 861 - 869